Henry R. Tribble

Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.

James E. Talmadge, Henry R. Tribble, Robin Pennington et al. · PubMed · 1987 · 134 citations

Life Sciences, Immunology, Pharmacology +15

Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.

James E. Talmadge, Hamblin Phillips, John Schindler et al. · PubMed · 1987 · 94 citations

Life Sciences, Immunology, Pharmacology +13

Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells

Cynthia M. Loeffler, Mark J. Smyth, Dan L. Longo et al. · The Journal of Immunology · 1992 · 92 citations · Full text

Life Sciences, Immunology, Oncology +17

Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

James E. Talmadge, O Bowersox, Henry R. Tribble et al. · PubMed · 1987 · 90 citations

Medicine, Oncology, Pharmacology +12

Immunomodulatory and therapeutic properties of bestatin in mice.

James E. Talmadge, Barbara Lenz, Robin Pennington et al. · PubMed · 1986 · 89 citations

Medicine, Immunology, Oncology +17